CLINICAL CHARACTERISTICS, ECHOCARDIOGRAPHY PARAMETERS IN ATRIAL FIBRILLATION PATIENTS WHO UNDERWENT RADIOFREQUENCY ABLATION

Phạm Trường Sơn1,, Phạm Văn Chính1
1 Department of Cardiology, Military Heart Institute, 108 Central Military Hospital

Main Article Content

Abstract

Objectives: to evaluate clinical characteristics, echocardiography parameters in atrial fibrillation patients who underwent radiofrequency ablation. Subjects and methods: A cross-sectional study was carried on 34 atrial fibrillation patients undergoing radiofrequency ablation at 108 Military Central Hospital from 3/2019 to 10/2021. All clinical characteristics were collected and echocardiography parameters wered measured. Results: mean age was 53.8 ± 13.5 years old, mainly men (70.6%), paroxysmal atrial fibrillation accounted for the majority (94.11%), the average duration of atrial fibrillation was 33.9 ± 33.3 months. The most common symptoms were palpitations (100%) and fatigue (70.6%), the severity of symptom was mostly grade 3 (58,8%). The majority of patients had cardiovascular risk factors (76.7%), the percentage of patients indicated for anticoagulation usage was 47.1%, whereas the percentage of patients taking anticoagulants was 32.4%. All patients had normal EF, diastolic dysfunction was seen in 82,4%. Conclusion: paroxysmal atrial fibrillation accounted for the majority, most patients had cardiovascular risk factors, the severity of symptom was mostly high grade, the number of patient taking anticoagulation was less than that as guided. 

Article Details

References

1. Michaud, G.F. and W.G. Stevenson (2021). Atrial Fibrillation. N Engl J Med, 2021. 384 (4): p. 353-361.
2. Hakalahti, A., et al (2015), Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Europace, 17 (3): p. 370-8.
3. Packer, D.L., et al (2019), Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA, 321 (13): p. 1261-1274.
4. Calkins, H., et al., (2017) HRS/EHRA/ECAS/ APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm, 14 (10): p. e275-e444.
5. Pappone, C., et al. (2006), A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol, 48 (11): p. 2340-7.
6. Staerk, L., et al. (2017), Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res, 120 (9): p. 1501-1517.
7. Phạm Trần Linh (2016), Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio. Luận án tiến sĩ, Học viện Quân y.